GENE ONLINE|News &
Opinion
Blog

2021-06-15| IPOSpecial

Is the Path to Public Market Smooth? A Candid Discussion on SPACs

by Daniel Ojeda
Share To
There are multiple ways for a company to raise money, from venture capital to the public offering of common stocks. One method that has garnered a lot of attention recently is the Special Purpose Acquisition Company (SPAC).
Recognizing the prominent role of SPACs in shaping the growth of biotech companies, an expert panel shared their experiences at the BIO Digital 2021 conference. The panel comprised of:

GO Prime with only $1.49 now

LATEST
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
Discover the Next Billion-Dollar Unicorn at the Biotech Innovation Funding Networking Event
2024-03-21
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top